14.76
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
8.61%
415.61
|
382.65 | 442.65 | 380.83 | 418.18 |
Cost Of Revenue |
9.59%
206.27
|
188.22 | 193.57 | 180.60 | 192.26 |
Gross Profit |
7.66%
209.33
|
194.43 | 249.07 | 200.24 | 225.92 |
|
243.93%
722.01
|
209.93 | 213.44 | 208.39 | 228.95 |
Benefits Costs and Expenses |
129.36%
946.56
|
412.69 | 420.11 | 401.20 | 433.36 |
Costs And Expenses |
133.15%
928.28
|
398.15 | 407.02 | 388.98 | 421.20 |
Operating Income/Loss |
3,208%
-512.67
|
-15.50 | 35.63 | -8.15 | -3.029 |
Income/Loss From Continuing Operations Before Tax |
1,668%
-530.95
|
-30.04 | 22.54 | -20.36 | -15.19 |
Income Tax Expense/Benefit, Deferred |
2,347%
-44.83
|
-1.832 | -6.988 | -9.043 | -1.844 |
Income Tax Expense/Benefit |
888.38%
-46.88
|
-4.743 | 3.106 | -9.667 | -2.783 |
Income/Loss From Continuing Operations After Tax |
1,814%
-484.07
|
-25.29 | 19.43 | -10.70 | -12.40 |
|
1,814%
-484.07
|
-25.29 | 19.43 | -10.70 | -12.40 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.30%
76.69
|
76.46 | -0.186 | 76.45 | 77.41 |
Diluted Average Shares |
0.30%
76.69
|
76.46 | -0.186 | 76.45 | 77.41 |
Basic Earnings Per Share |
1,812%
-6.31
|
-0.33 | 0.25 | -0.14 | -0.16 |
Diluted Earnings Per Share |
1,812%
-6.31
|
-0.33 | 0.25 | -0.14 | -0.16 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):